诺华制药 NVS 深 沪
已收盘 12-12 16:00:00 美东时间
132.57
+0.210
+0.16%
华盛通- 最 高133.01
- 今 开132.37
- 成交量 122.61万股
- 最 低 131.77
- 昨 收 132.36
- 总市值 2544.02亿
- 52周最高 134.24
- 市盈率 静 22.61
- 换手率 0.00%
- 52周最低 93.6329
- 委 比 -90.48%
- 总股本 19.19亿
- 历史最高 134.24
- 量 比 0.58
- 振 幅 0.94%
- 历史最低 6.9614
- 每 手 1
- 风险率 11.36%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Molecular Partners Forms Scientific Advisory Board to Accelerate Development of Targeted Radiotherapeutics
Molecular Partners AG, a clinical-stage biotech company, has announced the formation of a Scientific Advisory Board (SAB) for its radiopharmaceuticals, led by Prof. Ken Herrmann, a renowned nuclear medicine expert. The board includes industry leaders James Cook, Jason Lewis, Ph.D., and Michael Morris, M.D., aiming to guide the company's transition from early clinical validation to strategic development. The SAB will focus on refining scientific a...
12-11 12:00
Dyne upgraded at Oppenheimer on upcoming trial readout from Avidity
Oppenheimer upgraded Dyne Therapeutics (DYN) on Wednesday, citing a positive read-through from data that Novartis’ (NVS) buyout target Avidity Biosciences (RNA) is set to release this year from a late...
12-11 02:43
Pfizer is reportedly shedding hundreds of jobs in Switzerland
Pfizer (PFE) is reducing its Swiss workforce, with plans to cut its employee count to about 70 by the end of 2025 from 300 amid a broader cost-cutting drive, Bloomberg News reported, citing people fam...
12-11 01:13
Dyne Therapeutics prices $350 stock offering
Dyne Therapeutics (DYN) priced an upsized underwritten public offering of 18.98M shares at af $18.44 per share. The gross proceeds are expected to be $350.0 million. The offering is expected to close...
12-10 14:39
汇丰：上调多只欧洲医药股目标价
转自：财联社 【汇丰：上调多只欧洲医药股目标价】财联社12月10日电，汇丰银行将阿斯利康目标价从14640便士上调至16500便士；将葛兰素史克目标价从12...
12-10 14:22
Novartis' Investigational Drug Reports Longer Disease Control In Patients With Rare Blood Disorder
Novartis reports Phase 3 results showing that combining ianalumab with eltrombopag significantly extends disease control and improves sustained platelet response in ITP patients.
12-10 03:32
美股盘前要闻速递
①美股盘前，美股三大股指期货齐跌。 ②截至发稿，道指期货跌0.07%，标普500指数期货跌0.07%，纳指期货跌0.17%。 ③德国DAX指数涨0.26%，英国...
12-09 21:40
美股机会日报 | 特朗普最新讲话：可能降低部分商品关税！美联储传声筒称鲍威尔或“先降息再设限”
特朗普最新讲话：可能降低部分商品关税；美联储传声筒称鲍威尔或“先降息再设限”；阿里巴巴成立千问C端事业群，但盘前仍跌约2%>>
12-09 21:20
Tiny Biotech Terns Takes Aim At Novartis' Leukemia Blockbuster
Terns Pharma presented positive data from ongoing CARDINAL trial of TERN-701 in CML patients, showing high MMR rates and good safety profile.
12-09 20:51
美股异动丨诺华制药盘前涨近2%，布局过敏性疾病新靶点
诺华制药(NVS.US)盘前涨近2%，报132.73美元。消息面上，诺华制药与英国生物技术公司 Relation Therapeutics达成一项高达逾17亿美...
12-09 17:27
